Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing

B Toye1, W Woods, M Bobrowska

  • 1Department of Pathology and Laboratory Medicine, Ottawa General Hospital, University of Ottawa, Ontario, Canada. btoye@ogh.on.ca

Insights

PCR inhibition is rare in urine and infrequent in cervical samples for Chlamydia trachomatis testing, but common in urethral swabs. Several methods effectively reduce PCR inhibition, ensuring accurate test results.

Area of Science:

  • Clinical Microbiology
  • Molecular Diagnostics

Background:

  • Polymerase Chain Reaction (PCR) is crucial for detecting Chlamydia trachomatis.
  • Specimen inhibition can lead to false-negative results in PCR assays.

Purpose of the Study:

  • To determine the frequency of PCR inhibition in genital and urine specimens for Chlamydia trachomatis testing.
  • To evaluate methods for removing PCR inhibition.

Main Methods:

  • Utilized internal control DNA with the COBAS AMPLICOR C. trachomatis test.
  • Assessed inhibition in cervical swabs, urethral swabs, and urine samples.
  • Evaluated various inhibition removal methods: cold storage, freezing, dilution, and phenol-chloroform extraction.

Main Results:

  • PCR inhibition occurred in 7% of cervical swabs, 45% of urethral swabs, and 1.1% of urine samples.
  • Phenol-chloroform extraction was highly effective (99%) in eliminating inhibition.
  • Cold storage (86%) and dilution (86-89%) also demonstrated significant effectiveness.

Conclusions:

  • PCR inhibition is infrequent in urine and cervical samples but frequent in urethral samples for C. trachomatis detection.
  • Simple methods like cold storage, dilution, and phenol-chloroform extraction can significantly reduce PCR inhibition.
  • No positive specimens were missed due to inhibition in this study.